1036 related articles for article (PubMed ID: 29388198)
41. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
[TBL] [Abstract][Full Text] [Related]
42. In vitro fertilisation for unexplained subfertility.
Pandian Z; Gibreel A; Bhattacharya S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD003357. PubMed ID: 26583517
[TBL] [Abstract][Full Text] [Related]
43. Follicular flushing during oocyte retrieval in assisted reproductive techniques.
Georgiou EX; Melo P; Brown J; Granne IE
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD004634. PubMed ID: 29697138
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.
Bordewijk EM; Ng KYB; Rakic L; Mol BWJ; Brown J; Crawford TJ; van Wely M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001122. PubMed ID: 32048270
[TBL] [Abstract][Full Text] [Related]
45. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
[TBL] [Abstract][Full Text] [Related]
46. Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).
Ata B; Abou-Setta AM; Seyhan A; Buckett W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011809. PubMed ID: 29489026
[TBL] [Abstract][Full Text] [Related]
47. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
[TBL] [Abstract][Full Text] [Related]
48. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
49. Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.
Reavey J; Vincent K; Child T; Granne IE
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008720. PubMed ID: 27852101
[TBL] [Abstract][Full Text] [Related]
50. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; McNeil A; van Rumste MM
Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
[TBL] [Abstract][Full Text] [Related]
51. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)).
Lacey L; Hassan S; Franik S; Seif MW; Akhtar MA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001894. PubMed ID: 33730422
[TBL] [Abstract][Full Text] [Related]
52. Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle.
Glujovsky D; Pesce R; Miguens M; Sueldo C; Ciapponi A
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD013827. PubMed ID: 38032057
[TBL] [Abstract][Full Text] [Related]
53. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Franik S; Eltrop SM; Kremer JA; Kiesel L; Farquhar C
Cochrane Database Syst Rev; 2018 May; 5(5):CD010287. PubMed ID: 29797697
[TBL] [Abstract][Full Text] [Related]
54. Assisted reproductive technologies for male subfertility.
Cissen M; Bensdorp A; Cohlen BJ; Repping S; de Bruin JP; van Wely M
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD000360. PubMed ID: 26915339
[TBL] [Abstract][Full Text] [Related]
55. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection.
Kamath MS; Mascarenhas M; Kirubakaran R; Bhattacharya S
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD003416. PubMed ID: 32827168
[TBL] [Abstract][Full Text] [Related]
56. Temperature of embryo culture for assisted reproduction.
Baak NA; Cantineau AE; Farquhar C; Brison DR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012192. PubMed ID: 31529804
[TBL] [Abstract][Full Text] [Related]
57. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006105. PubMed ID: 25406011
[TBL] [Abstract][Full Text] [Related]
58. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
59. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
[TBL] [Abstract][Full Text] [Related]
60. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.
Brown J; Farquhar C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002249. PubMed ID: 27976369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
